Mistrial Declared In First Androgel Bellwether

Law360, Chicago (June 12, 2017, 12:41 PM EDT) -- The first attempt to bring AbbVie Inc. to trial over the allegedly hidden side effects of its testosterone replacement drug Androgel ended in a mistrial Monday after the lead plaintiff's attorney fell ill.

One week after Jeffrey Konrad brought before a jury his allegations that the drug caused him to have a heart attack in 2010, U.S. District Judge Matthew Kennelly called the trial off.

The judge's clerk, Pam Geringer, said the mistrial was called due to health issues experienced by one of the parties and lead defense attorney David Bernick of Paul Weiss Rifkind Wharton & Garrison LLP confirmed that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)

Judge

Subscribers Only

Date Filed

January 29, 2015

Law Firms

Companies

Government Agencies